GlassScriptPhysician profile
Jenny Tran
NPI 1144794785
$920.13
in general payments reported to CMS, 2019-2025
11 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $15.44 · 2023: $274 · 2024: $46.81 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $226.34 | 2025 | Talvey, Tecvayli, Carvykti |
| Lilly USA, LLC | $121.50 | 2023 | |
| Novartis Pharmaceuticals Corporation | $120.64 | 2023 | |
| Stemline Therapeutics INC. | $119.74 | 2021 | |
| Legend Biotech USA INC. | $111.82 | 2025 | Carvykti |
| Genzyme Corporation | $101.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.81 | 2024 | Livtencity |
| Acrotech Biopharma INC. | $24.27 | 2021 | |
| Daiichi Sankyo INC. | $16.91 | 2023 | |
| Pfizer INC. | $15.44 | 2022 | |
| Abc Home Medical Supply, INC. | $15.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.